Evidence map›Paper›PMID 36421141›Full record

ReviewBiosensors2022

Biomedical Applications of Microfluidic Devices: A Review.

Ghazaleh Gharib, İsmail Bütün, Zülâl Muganlı, Gül Kozalak, İlayda Namlı, Seyedali Seyedmirzaei Sarraf, Vahid Ebrahimpour Ahmadi, Erçil Toyran, Andre J van Wijnen, Ali Koşar

Open access · goldAbstract readReview
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ghazaleh GharibFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-0082-5120
İsmail BütünFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0003-4668-5036
Zülâl MuganlıFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-7045-9920
Gül KozalakFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-2928-6474
İlayda NamlıFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-3776-5176
Seyedali Seyedmirzaei SarrafFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0003-3422-753X
Vahid Ebrahimpour AhmadiFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0001-9153-4128
Erçil ToyranFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-4972-3678
Andre J van WijnenDepartment of Biochemistry, University of Vermont, 89 Beaumont Avenue, Burlington, VT 05405, USA.ORCID 0000-0002-4458-0946
Ali KoşarFaculty of Engineering and Natural Science, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0001-6283-6717
Sabancı Üniversitesi · TRUniversity of Vermont · US

Funding

Scientific and Technological Research Council of Turkey 20AG012
6 · The paper itself

Abstract

Both passive and active microfluidic chips are used in many biomedical and chemical applications to support fluid mixing, particle manipulations, and signal detection. Passive microfluidic devices are geometry-dependent, and their uses are rather limited. Active microfluidic devices include sensors or detectors that transduce chemical, biological, and physical changes into electrical or optical signals. Also, they are transduction devices that detect biological and chemical changes in biomedical applications, and they are highly versatile microfluidic tools for disease diagnosis and organ modeling. This review provides a comprehensive overview of the significant advances that have been made in the development of microfluidics devices. We will discuss the function of microfluidic devices as micromixers or as sorters of cells and substances (e.g., microfiltration, flow or displacement, and trapping). Microfluidic devices are fabricated using a range of techniques, including molding, etching, three-dimensional printing, and nanofabrication. Their broad utility lies in the detection of diagnostic biomarkers and organ-on-chip approaches that permit disease modeling in cancer, as well as uses in neurological, cardiovascular, hepatic, and pulmonary diseases. Biosensor applications allow for point-of-care testing, using assays based on enzymes, nanozymes, antibodies, or nucleic acids (DNA or RNA). An anticipated development in the field includes the optimization of techniques for the fabrication of microfluidic devices using biocompatible materials. These developments will increase biomedical versatility, reduce diagnostic costs, and accelerate diagnosis time of microfluidics technology.

Indexed as

Biosensing TechniquesMicrofluidic Analytical TechniquesDNALab-On-A-Chip DevicesMicrofluidicsDNAacoustophoresisbiomedical applicationsbiosensorscancer diagnosiscell sortingdielectrophoresisdisease modelingelectrophoresislab-on-a-chipmagnetophoresismicromixersoptical trappingorgan-on-a-chipparticle enrichmentparticle separationpoint-of-carepressure fieldsthermal fields

Identifiers

PMID36421141
PMCPMC9688231
OpenAlexW4309605130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.